Rosuvastatin as treatment for non alcoholic steatohepatitis (NASH) and highly active antiretroviral therapy (HAART)-dystipidaemia: New treatment for global dangers

被引：4
作者：
Ahmed, MH [1 ]
机构：
[1] Southampton Gen Hosp, Dept Chem Pathol, Southampton SO16 6YD, Hants, England
来源：
MEDICAL HYPOTHESES | 2006年 / 66卷 / 02期
关键词：
D O I：
10.1016/j.mehy.2005.09.003
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：440 / 441
页数：2
相关论文
共 6 条
[1]   The safety of rosuvastatin as used in common clinical practice - A postmarketing analysis [J].
Alsheikh-Ali, AA ;
Ambrose, MS ;
Kuvin, JT ;
Karas, RH .
CIRCULATION, 2005, 111 (23) :3051-3057
[2]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[3]   Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study [J].
Calza, L ;
Colangeli, V ;
Manfredi, R ;
Legnani, G ;
Tampellini, L ;
Pocaterra, D ;
Chiodo, F .
AIDS, 2005, 19 (10) :1103-1105
[4]  
Clark JM, 2001, GASTROENTEROLOGY, V120, pA65
[5]   Medical progress - Cardiovascular risk and body-fat abnormalities in HIV-infected adults. [J].
Grinspoon, S ;
Carr, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (01) :48-62
[6]   Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvalstaltin, and pravastatin across doses (STELLAR* trial) [J].
Jones, PH ;
Davidson, MH ;
Stein, EA ;
Bays, HE ;
McKenney, JM ;
Miller, E ;
Cain, VA ;
Blasetto, JW ;
STELLAR Study Grp .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (02) :152-160
1